Skip to main content
Stonvex
Loading…
Home
Activity
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
Log in
Get Started
← Back to rankings
MLYS
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Loading latest news…
52w high -42.5%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
therapeutics
mineralys
nasdaq
2023
results
financial
lorundrostat
hypertension
announced
target
clinical
trial
fourth
after
trading
last
high
aldosterone
price
today
MLYS
Mineralys Therapeutics, Inc. Common Stock
Stonvex
StonvexStonvexStonvexStonvex